Compass Therapeutics, Inc. (CMPX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 195.69M | 209.82M | 221.12M | 106.19M | 124.14M | 132.75M | 141.14M | 153.55M | 158.61M | 153.88M | 166.58M | 175.27M |
| Cash & Short-Term Investments | 194.69M | 208.91M | 219.9M | 100.95M | 112.64M | 126.72M | 135.4M | 146.23M | 156.25M | 152.46M | 163.7M | 168.75M |
| Cash Only | 55.17M | 30.64M | 46.21M | 22.86M | 41.05M | 43.48M | 36.8M | 19.4M | 23.67M | 24.23M | 30.43M | 19.28M |
| Short-Term Investments | 139.52M | 178.26M | 173.68M | 78.09M | 71.59M | 83.24M | 98.6M | 126.82M | 132.58M | 128.23M | 133.28M | 149.47M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1M | 913K | 0 | 5.25M | 11.51M | 6.03M | 5.74M | 7.32M | 2.36M | 1.42M | 2.88M | 6.52M |
| Total Non-Current Assets | 9.48M | 9.77M | 10.14M | 10.5M | 7.31M | 7.65M | 8.01M | 2.06M | 2.53M | 2.99M | 3.45M | 3.91M |
| Property, Plant & Equipment | 8.91M | 9.2M | 9.57M | 9.94M | 6.74M | 7.08M | 7.44M | 1.75M | 2.21M | 2.67M | 3.13M | 3.59M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 0.43x | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 568K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 568K | 568K | 568K | 0 | 568K | 568K | 568K | 320K | 320K | 320K | 320K | 320K |
| Total Assets | 205.17M | 219.59M | 231.26M | 116.7M | 131.45M | 140.4M | 149.15M | 155.61M | 161.14M | 156.88M | 170.04M | 179.18M |
| Asset Turnover | - | - | - | - | - | - | - | 0.01x | - | - | - | - |
| Asset Growth % | 56.08% | 56.4% | 55.05% | -25.01% | -18.43% | -10.5% | -12.28% | -13.15% | -14.27% | -21.42% | 33.01% | 27.75% |
| Total Current Liabilities | 10.28M | 13.97M | 12.41M | 13.86M | 14.9M | 8.87M | 4.43M | 9.51M | 3.89M | 7.8M | 9.12M | 9.7M |
| Accounts Payable | 906K | 1.58M | 3.1M | 2.6M | 1.58M | 2.25M | 960K | 1.19M | 854K | 4.09M | 2.31M | 724K |
| Days Payables Outstanding | 304.61 | 581.84 | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.37M | 1M | 0 | 271K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8M | 11.38M | 0 | 8.99M | 1.49M | 2.79M | 0 | 0 | 792K | 1.94M | 1.43M | 989K |
| Current Ratio | 19.04x | 15.02x | 17.82x | 7.66x | 8.33x | 14.96x | 31.84x | 16.15x | 40.74x | 19.73x | 18.26x | 18.07x |
| Quick Ratio | 19.04x | 15.02x | 17.82x | 7.66x | 8.33x | 14.96x | 31.84x | 16.15x | 40.74x | 19.73x | 18.26x | 18.07x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 8.42M | 8.83M | 9.23M | 9.63M | 6.27M | 6.3M | 6.32M | 0 | 189K | 536K | 869K | 1.2M |
| Long-Term Debt | 8.42M | 8.83M | 0 | 9.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 9.23M | 0 | 6.27M | 6.3M | 6.32M | 0 | 189K | 536K | 869K | 1.2M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 18.7M | 22.8M | 21.65M | 23.49M | 21.17M | 15.17M | 10.75M | 9.51M | 4.08M | 8.34M | 9.99M | 10.89M |
| Total Debt | 9.79M | 9.83M | 9.87M | 9.9M | 6.38M | 6.63M | 6.88M | 1.09M | 1.41M | 1.73M | 2.04M | 2.34M |
| Net Debt | -45.38M | -20.81M | -36.34M | -12.95M | -34.67M | -36.85M | -29.92M | -18.32M | -22.26M | -22.5M | -28.38M | -16.93M |
| Debt / Equity | 0.05x | 0.05x | 0.05x | 0.11x | 0.06x | 0.05x | 0.05x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 186.47M | 196.79M | 209.61M | 93.21M | 110.28M | 125.23M | 138.4M | 146.1M | 157.06M | 148.54M | 160.04M | 168.29M |
| Equity Growth % | 69.09% | 57.14% | 51.46% | -36.2% | -29.79% | -15.69% | -13.53% | -13.18% | -10.39% | -18.22% | 37.83% | 32.58% |
| Book Value per Share | 1.00 | 1.06 | 1.52 | 0.67 | 0.80 | 0.92 | 1.01 | 1.06 | 1.15 | 1.16 | 1.26 | 1.33 |
| Total Shareholders' Equity | 186.47M | 196.79M | 209.61M | 93.21M | 110.28M | 125.23M | 138.4M | 146.1M | 157.06M | 148.54M | 160.04M | 168.29M |
| Common Stock | 18K | 18K | 53K | 14K | 14K | 13K | 14K | 14K | 14K | 13K | 13K | 13K |
| Retained Earnings | -449.49M | -431.17M | -415.46M | -401.2M | -381.32M | -364.68M | -349.65M | -339.17M | -326.1M | -315.31M | -301.89M | -291.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Accumulated OCI | -159K | 280K | 274K | 208K | 190K | 210K | 486K | -91K | -90K | 37K | -430K | -507K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |